Enclomiphene citrate
| Nazwa produktu | Enclomiphene citrate |
|---|---|
| Numer CAS | 7599-79-3 |
| Inne nazwy | trans-Clomiphene citrate; (E)-Clomiphene citrate; 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine citrate |
| Wzór cząsteczkowy | C26H28ClNO·C6H8O7 |
| Masa cząsteczkowa | 598.1 g/mol (citrate salt) |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Oznaczenie (HPLC) | ≥98.0% (anhydrous basis) |
| Strata przy suszeniu | ≤0.5% |
| Popiół po spaleniu | ≤0,11 TP3T |
| Metale ciężkie | ≤10 ppm |
| Rozpuszczalność | Sparingly soluble in water, freely soluble in ethanol, methanol |
| Opakowanie | Beczka na włókna o pojemności 25 kg z podwójną wkładką z polietylenu |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Synonimy: trans-Clomiphene citrate, (E)-Clomiphene citrate, Enclomiphene dihydrogen citrate, 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine citrate
Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that has drawn considerable attention in both clinical research and pharmaceutical manufacturing. Unlike its cis counterpart zuclomiphene, which exhibits estrogenic activity, enclomiphene acts as a pure estrogen antagonist in the hypothalamus and pituitary. This distinct pharmacological profile has positioned it as a compound of interest for developing therapies targeting testosterone deficiency and related endocrine disorders.
Chemically, enclomiphene citrate belongs to the triphenylethylene class, sharing structural similarities with tamoxifen and other well-known SERMs. The molecule features a chloro-substituted stilbene core with a diethylaminoethoxy side chain, and its citrate salt form enhances aqueous solubility and stability. The trans configuration is critical for its antagonistic properties; even minor contamination with the cis isomer can significantly alter the pharmacological response, making stereochemical purity a key quality parameter.
In the pharmaceutical supply chain, enclomiphene citrate is typically produced under cGMP conditions and is available in high-purity grades suitable for formulation development and clinical trial materials. It is most commonly used in the development of oral capsules or tablets for hormone modulation, and as a reference standard in analytical laboratories. Its rising profile in men’s health research has led to increased demand for reliable, well-documented sources of this active pharmaceutical ingredient.
| Parametr | Specyfikacja |
|---|---|
| Oznaczenie (HPLC) | ≥98,01 TP3T |
| Identyfikacja | IR, HPLC retention time conforms to standard |
| Cis-isomer | ≤0.5% |
| Strata przy suszeniu | ≤0.5% |
| Popiół po spaleniu | ≤0,11 TP3T |
| Metale ciężkie | ≤10 ppm |
| Wartości graniczne dla mikroorganizmów | Total aerobic count ≤1000 CFU/g; Yeast & Mold ≤100 CFU/g; E. coli absent |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China